Biosis Healing won the "2019 Most Innovative Enterprise Award"

by

The 8th China Finance and Economics Summit was held in Beijing from July 11 to 12, 2019. The theme of the Summit was "New Era: Big Change and New Power". Under the joint evaluation of the evaluation committee composed of well-known research institutions, consulting companies, experts, scholars and media leaders, Beijing Biosis Healing Biological Technology Co., Ltd. stood out and won the "Most Innovative Enterprise Award of the Year".

Biosis Healing won the "2019 most innovative enterprise" award of this summit.

"2019 Most Innovative Enterprise Award" is an important award in the field of enterprise innovation in the 8th Finance and Economics Summit, aiming at strengthening the leading role of innovative benchmarking enterprises, promoting innovative culture, publicizing excellent enterprises and technological innovation models, and promoting the development of Chinese enterprise innovation.

       

Speech by Mr. Zhao Yanrui, director of Beijing Biosis Healing Biological Technology Co., Ltd

Zhao Yanrui, chief patent officer and assistant chairman of Biosis Healing, delivered a keynote speech as a representative of the enterprise. He emphasized that "in today's society, no matter what kind of industry we are engaged in, the only way for the enterprise to survive and develop is to attach importance to the continuous innovation and scientific research as well as enhance the core competitiveness of the enterprise." He also said that "this award is a driving force and encouragement for us. We will continue to make scientific research and innovation, and continuously bring new energy into the enterprise.".

Zhao Yanrui, director of Beijing Biosis Healing Biological Technology Co., Ltd., received the award on the stage.

After the meeting, director Zhao Yanrui also accepted interviews from Netease News and other well-known media. He presented his opinion from the company's core competitiveness, talent training, technical advantages, the companies’s development under the influence of trade disputes between China and the United States and other aspects.

Biosis Healing has been committed to providing advanced comprehensive solutions for tissue repair and minimally invasive surgery, and promoting surgical clinical innovation through innovative research. This award is closely related to Biosis Healing’s the emphasis on intellectual property rights, basic research and personnel training for many years.

Intellectual property rights: more than 100 patents at home and abroad. The core technology in the United States, Britain, Germany and Japan have been granted patent. For basic materials, products, production processes, manufacturing equipment, Biosis Healing have complete independent intellectual property rights. At the same time, under the support of the Daxing District Science and Technology Commission, Biosis Healing carry out the implementation of intellectual property standards work, so that the acquisition and use of intellectual property rights will be more standard.

Basic Research: Our non-crosslinked extracellular matrix source material project has been listed as a key project in the field of new materials in the 12th Five-Year Plan, and the product transformation process has been funded by Zhongguancun Major Frontier Original Technology Industrialization Project.

Talent training: We have carried out in-depth cooperation with universities and research institutes at home and abroad. In 2018, we sent Dr. Chen Yi, head of R & D, to visit the United States for one year, and at the end of 2018, we were approved to become a post-doctoral research workstation, and now there are three post doctors working in station.

Biosis Healing’s Core Product Non-crosslinked Biological Materials